LOUISE LALONDE: Open Payments
NPI 1669493367 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 13 payments from 9 companies in 2025. Trend: 2023 $929 · 2024 $1,132 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| PFIZER INC. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| W. L. Gore & Associates, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Medline Industries LP | 1 | $14 |
Products named: ALINITY, LEQVIO, ELIQUIS, JARDIANCE, INSPIRE, Wegovy, GORE CARDIOFORM Septal Occluder, FARXIGA.
Industry payments across CA — which companies pay providers there.
